Key Takeaways from Hydrogenics' (HYGS) Q2 Report
Tweet Send to a Friend
Roth Capital affirms Hydrogenics (Nasdaq: HYGS) at Buy with a target price of $30 following Q2 results reported last week.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE